Effect of cyclin D1 on the prognosis of multiple myeloma in Egyptian patients / Menna Alla Mohie Eldein Elsayed Sherif ; Supervised Lalia Abdelrahman Hegazy , Osman Mohamed Mansour , Reham Ahmed Rashed
Material type:
- على التطور الأكلينيكى فى المرضى المصريين المصابين بالورم النقوى المتعدد D1 تأثير السيكلين [Added title page title]
- Issued also as CD
Item type | Current library | Home library | Call number | Copy number | Status | Barcode | |
---|---|---|---|---|---|---|---|
![]() |
قاعة الرسائل الجامعية - الدور الاول | المكتبة المركزبة الجديدة - جامعة القاهرة | Cai01.11.07.M.Sc.2018.Me.E (Browse shelf(Opens below)) | Not for loan | 01010110075930000 | ||
![]() |
مخـــزن الرســائل الجـــامعية - البدروم | المكتبة المركزبة الجديدة - جامعة القاهرة | Cai01.11.07.M.Sc.2018.Me.E (Browse shelf(Opens below)) | 75930.CD | Not for loan | 01020110075930000 |
Thesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of Clinical and Chemical Pathology
Background: Multiple myeloma is a disseminated malignancy of monoclonal plasma cells, diagnosed by {u2265}10% clonal bone marrow plasma cells or a biopsy infiltrated by plasma cells along with one or more of the multiple myeloma defining events (MDE): CRAB (hypercalcemia, renal failure, anemia, or lytic bone lesions). Aim of work: Correlating Cyclin D1 with the prognosis of the patients. Subjects, materials and methods: Bone marrow biopsy of 50 patients newly diagnosed as Multiple myeloma were examined by immunohistochemistry for Cyclin D1, then these patients were followed up for a year. Results: There was significant correlation between Cyclin D1 and response of the patients. Conclusion: Cyclin D1 positive patients were found more likely to have worse prognosis than the negative ones
Issued also as CD
There are no comments on this title.